Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation

American Journal of Transplantation

Volumn 3, Issue 10, 2003, Pages 1273-1277

  Liu, Lawrence U ^a   Schiano, Thomas D ^a   Lau, Nancy ^a   O'Rourke, Marian ^a   Min, Albert D ^a   Sigal, Samuel H ^a   Drooker, Martin ^b   Bodenheimer Jr , Henry C ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Liver; Methadone; Transplantation

Indexed keywords

DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG DEPENDENCE; DRUG USE; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; OUTCOMES RESEARCH; PROGNOSIS; RECIDIVISM; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT INDICATION; UNITED STATES;

FEMALE; GRAFT SURVIVAL; HEROIN DEPENDENCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; METHADONE; MIDDLE AGED; NARCOTICS; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME;

EID: 0141669248     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00199.x     Document Type: Article

References (18)

1. Koch M, Banys P. Liver transplantation and opioid dependence. JAMA 2001; 285: 1056-1058.
2. Backmund M, Meyer K, Von Zielonka M, Eichenlaub D. Treatment of hepatitis C infection in injection drug users. Hepatology 2001; 34: 188-193.
3. Chetwynd J, Brunton C, Blank M, Plumridge E, Baldwin D. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme. N Z Med J 1995; 108: 364-366.
4. McCarthy JJ, Flynn N. Hepatitis C in methadone maintenance patients: prevalence and public policy implications. J Addict Dis 2001; 20: 19-31.
5. National Institute of Health Consensus Development Conference (June 10-12 2002) Statement. Management of Hepatitis C 2002: http://www.consensus.nih.gov.
6. National Institute of Health Consensus Statement. Effective medical treatment of opiate addiction. JAMA 1998; 280: 1936-1943.
7. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med 2000; 67: 347-364.
8. Awad JA, Chin B. Survey of methadone maintenance policies of US liver transplant centers. Hepatology 2000; 32: 338A.
9. Kanchana TP, Kaul V, Manzarbeitia C et al. Liver transplantation for patients on methadone maintenance. Liver Transpl 2002; 8: 778-782.
10. Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999; 107: 2S-9S.
11. Sylvestre DL. Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug Alcohol Depend 2002; 67: 117-123.
12. Leavitt SB, Shinderman M, Maxwell S, Eap CB, Paris P. When 'enough' is not enough: new perspectives on optimal methadone maintenance dose. Mt Sinai J Med 2000; 67: 404-411.
13. Stowe J, Kotz M. Addiction medicine in organ transplantation. Progress Transplant 2001; 11: 50-57.
14. Fabrega E, Crespo J, Casafont F, De Ias Heras G, de la Pena J, Pons-Romero F. Alcohol recidivism after liver transplantation for alcoholic cirrhosis. J Clin Gastroenterol 1998; 26: 204-206.
15. Pageaux GP, Michel J, Coste V et al. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut 1999; 45: 421-426.
16. Gordon MJV, White R, Matas AJ et al. Renal transplantation in patients with a history of heroin abuse. Transplantation 1986; 42: 556-557.
17. Scimeca MM, Savage SR, Portenoy R, Lowinson J. Treatment of pain in methadone-maintained patients. Mt Sinai J Med 2000; 67: 412-422.
18. Wiesner RH, Demetris AJ, Belle SH et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998; 28: 638-645.